As the symposium unfolds over 3.5 days, attendees will experience a series of plenary talks delivered by award recipients, providing an unparalleled opportunity to engage with groundbreaking science firsthand. These lectures will delve deeply into the intricacies of protein folding dynamics, elucidation of enzyme catalysis mechanisms, and the innovative use of computational models to predict protein interactions and functions. The awardees’ investigations not only enhance the fundamental understanding of protein behavior but also propel advancements in therapeutic development, biotechnology, and synthetic biology.

Proteins, as essential macromolecules, execute a vast array of cellular functions, including catalyzing biochemical reactions, signal transduction, and structural support. The award-winning research showcases novel approaches to exploring protein conformational landscapes using advanced techniques like cryo-electron microscopy, NMR spectroscopy, and single-molecule fluorescence. These cutting-edge methodologies have permitted visualization of transient states and molecular intermediates that were previously inaccessible, thereby providing critical insights into protein dynamics that govern biological activity.

The Society’s recognition highlights researchers who have bridged gaps between theory and practice. For instance, some honorees have innovatively combined experimental data with machine learning algorithms to map protein-protein interaction networks, revealing previously hidden regulatory pathways. Others have engineered synthetic proteins with tailor-made functions, triggering new avenues in drug design and industrial biocatalysis. Such integrative and multidisciplinary strategies exemplify the future trajectory of protein science, emphasizing precision and predictive capacity.

In addition to structural and functional studies, the awarded research emphasizes the biological significance of post-translational modifications (PTMs) and their role in modulating protein activity. By developing novel mass spectrometry-based workflows and chemical probes, these scientists have enabled comprehensive profiling of PTMs, unearthing modifications that control signal transduction processes and protein degradation. This line of work holds immense promise for understanding disease mechanisms and identifying novel biomarkers.

One of the central themes emerging from the imminent symposium is the interrogation of protein misfolding and aggregation, phenomena critically implicated in neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The laureates’ investigations utilize diverse approaches ranging from biophysical characterizations of amyloid fibrils to high-throughput screening for aggregation inhibitors. These studies not only advance our grasp on pathological protein states but also propose novel therapeutic targets to counteract protein aggregation-linked maladies.

The symposium will also spotlight breakthroughs in membrane protein research, a notoriously challenging sector due to the hydrophobic nature and complex milieu of these proteins. Awardees in this category have unveiled mechanisms of membrane transport, signal transduction, and receptor activation through the application of innovative detergents, nanodiscs, and lipidic cubic phase crystallization. Their success in overcoming traditional barriers sets the stage for therapeutic exploitation of membrane-bound targets, crucial in drug discovery.

Moreover, the 40th Anniversary Symposium promises stimulating discussions around the evolution of protein engineering. Award-winning scientists have harnessed directed evolution, computational design, and deep mutational scanning to create enzymes with enhanced stability, specificity, and catalytic efficiency. Such engineered proteins are transforming industrial processes, offering environmentally friendly alternatives and improving yield in pharmaceutical manufacturing.

The impact of these awards extends beyond the bench, as many recipients have contributed to the establishment of community resources, open-access databases, and collaborative platforms that democratize protein scientific knowledge. By fostering global cooperation and data sharing, they aid in accelerating discovery and the translation of fundamental research into practical applications, including personalized medicine and synthetic biology constructs.

Reflecting on the historical significance of the Protein Society’s 40-year legacy, the 2026 awards resonate as a testament to the relentless curiosity and innovation in protein science. From the elucidation of the first protein structures to the integration of artificial intelligence in protein prediction, the trajectory mapped by these accomplished scientists frames an exciting future. Their work embodies the convergence of experimental rigor and computational prowess, driving the frontier of molecular life sciences.

Each plenary session during the symposium will not only celebrate these momentous scientific achievements but also inspire the next generation of researchers to tackle the complex challenges of protein science. The awardees’ stories, rich with technical depth and visionary insights, reinforce the foundational role of proteins in health, disease, and biotechnology, promising continued advancements that will impact society broadly.

As the global community anticipates this landmark event, it is clear that the 2026 Protein Society Awardees represent the vanguard of scientific excellence. Their contributions illuminate the nuanced and multifaceted nature of proteins, highlighting the relentless pursuit of knowledge that defines this vibrant field. With their groundbreaking findings set to be showcased in Boston, the symposium is poised to be a defining moment in the ongoing evolution of protein science.

Subject of Research: Protein science, including structural biology, enzymology, protein folding, post-translational modifications, membrane proteins, and protein engineering.

Article Title: The Protein Society Unveils 2026 Award Winners at 40th Anniversary Symposium Celebrating Transformative Advances in Protein Science

News Publication Date: Not specified in the original content.

Web References: Not provided.

References: Not provided.

Image Credits: Not provided.

Keywords

Protein Society, Protein Science, 2026 Protein Society Awards, Protein Folding, Enzymology, Structural Biology, Post-translational Modifications, Membrane Proteins, Protein Engineering, Cryo-EM, NMR Spectroscopy, Proteomics, Synthetic Biology, Drug Discovery, Machine Learning in Biology, Neurodegenerative Diseases

Traditional directed evolution techniques rely on iterative cycles of mutation and selection, typically requiring manual intervention and extended timeframes—often spanning weeks or months to achieve meaningful results. This laborious process involves repeated DNA manipulations, screening, and selection, limiting throughput and scalability. By contrast, T7-ORACLE integrates a remarkable genetic engineering feat: the establishment of a secondary, virus-derived DNA replication system within the well-studied bacterium Escherichia coli, which operates independently from the host’s genome replication. This orthogonal T7 replisome, derived from bacteriophage T7, introduces mutations at unprecedented rates—estimated to be 100,000 times higher than the natural background mutation frequency—exclusively targeting plasmid DNA while leaving the host genome untouched and thus preserving cellular viability.

The core innovation underpinning T7-ORACLE is the orthogonal replication system’s ability to achieve continuous, high-frequency mutagenesis focused on plasmids that harbor genes of interest. Through engineering the T7 DNA polymerase to be error-prone, researchers enable rapid and ongoing diversification of target proteins encoded on these plasmids without compromising host cell health. This decoupling of mutagenesis from the primary replication machinery circumvents common issues of genomic instability that plague other continuous evolution methods. As a result, the evolutionary process is synchronized with the bacterial division cycle, granting a new round of mutation and selection every approximately 20 minutes.

Current continuous evolution platforms have suffered from either technical complexity or insufficient mutation rates, limiting their practical utility in labs. T7-ORACLE addresses these challenges by combining the advantages of the T7 bacteriophage replication system with the genetically tractable, fast-growing E. coli model organism. This fusion not only drastically accelerates evolutionary timelines but also seamlessly integrates with standard molecular biology workflows. The system’s scalability and ease of use hold promise for widespread adoption in protein engineering efforts across academic and industrial settings.

To exemplify the capabilities of T7-ORACLE, the researchers implemented a proof-of-concept experiment using the TEM-1 β-lactamase gene—a prototypical enzyme conferring antibiotic resistance. By subjecting E. coli cells harboring the orthogonal replication system and TEM-1 variants to continuously escalating doses of diverse antibiotics, the team observed rapid emergence of evolved enzyme variants capable of tolerating antibiotic levels up to 5,000 times greater than the ancestral form. Remarkably, many of the mutations identified during this accelerated evolution closely mirrored those documented in clinical isolates, underscoring the system’s fidelity in recapitulating real-world evolutionary trajectories. Some evolved variants even exhibited novel mutational combinations that enhanced resistance beyond known clinical benchmarks.

Despite using antibiotic resistance as a demonstrative model, the implications of T7-ORACLE extend far beyond microbial resistance studies. The platform’s modularity enables it to evolve virtually any protein of interest—from human enzymes to viral antigens—simply by integrating the corresponding genes into plasmids compatible with E. coli. This opens expansive avenues for engineering next-generation biotherapeutics, including highly selective antibodies and proteases tailored to degrade disease-related proteins in cancer and neurodegenerative pathways. The rapid timeframe from gene insertion to evolved protein facilitates accelerated discovery and optimization cycles, dramatically reducing development pipelines.

The technical elegance of T7-ORACLE lies not only in its hypermutation rates but also in its preservation of host cell health. By confining mutagenic activity exclusively to the plasmid replicon, the system maintains genomic integrity and cellular viability—overcoming a crucial bottleneck that limits many mutagenesis-based approaches. This orthogonality is achieved through the design of a dedicated T7 replisome that operates independently of the host’s replication enzymes, a significant leap inspired by earlier orthogonal replication systems implemented in yeast (OrthoRep) and E. coli (EcORep). However, compared to these predecessors, T7-ORACLE offers a superior combination of rapid bacterial growth, high transformation efficiency, stringent mutagenesis, and compatibility with common laboratory techniques.

The broader vision for T7-ORACLE includes not only evolving proteins for improved or novel functions but also engineering entirely new biological polymers. Scientists involved envision extending the system to evolve specialized polymerases capable of replicating synthetic nucleic acids—chemical analogs of DNA and RNA with enhanced or altered properties. Such an advancement would usher in a new era of synthetic genomics, enabling the construction of organisms with fundamentally reprogrammed genetic architectures. This frontier remains largely unexplored but represents a tantalizing horizon for bioengineering and synthetic biology.

Importantly, the ease of implementing T7-ORACLE ensures accessibility for researchers already familiar with E. coli culture and standard molecular biology protocols. The platform does not require specialized equipment or complex workflows, lowering the barrier to entry for laboratories worldwide. This democratization of accelerated evolution technology could catalyze rapid advances across diverse areas of biomedical research, from drug development to environmental biocatalysis.

The development of T7-ORACLE reflects a paradigm shift in how scientists approach protein evolution. As co-senior author Pete Schultz articulates, the system acts as a “fast-forward button” on evolution, enabling the precise, continuous, and scalable generation of new protein variants with functional improvements. Co-senior author Christian Diercks reinforces that T7-ORACLE merges rational protein design principles with continuous evolution, creating a hybrid toolkit that will enhance efficiency in the discovery of therapeutic molecules.

Supported by funding from the National Institutes of Health, this study represents a milestone in synthetic biology and protein engineering. Its publication in Science signals broad recognition of the innovative methodology and its potential impact on medicine, research, and industrial biotechnology. As scientists continue to refine and expand T7-ORACLE, the system’s ability to rapidly produce specialized enzymes, antibodies, and other biologics could revolutionize approaches to treating cancer, neurodegeneration, and a myriad of human diseases.

Looking ahead, the research team at Scripps Research is focusing on applying T7-ORACLE to evolve human-derived enzymes for clinical use and to tailor proteases with enhanced specificity for cancer-associated proteins. These efforts aim to translate the platform’s accelerated evolutionary capability into tangible therapeutic applications, potentially speeding up drug development timelines and improving treatment efficacy. With T7-ORACLE, the promise of bringing evolution’s power directly into the laboratory has become a reality.

Subject of Research: Accelerated protein evolution using an orthogonal T7 plasmid replication system in Escherichia coli.

Article Title: An orthogonal T7 replisome for continuous hypermutation and accelerated evolution in E. coli.

News Publication Date: 7-Aug-2025.

Web References:
Science Article

Image Credits: Scripps Research.

Keywords: Proteins, Synthetic biology, Directed evolution, Hypermutation, E. coli, Orthogonal replication, Therapeutic enzymes, Antibiotic resistance, Protein engineering.

The landscape of protein design has been transformed with the advent of advanced computational techniques. Notably, the introduction of deep learning-based frameworks has revolutionized the way researchers can predict protein behavior and design new proteins. One such breakthrough is the ProteinMPNN framework, which has shown remarkable promise in expanding the sequence space available for synthetic binding proteins (SBPs). Unlike traditional approaches that rely heavily on energy functions to predict stability and folding, ProteinMPNN utilizes machine learning methodologies that may enhance the accuracy of these predictions significantly.

Recent research conducted by a team led by Dr. Weiwei Xue from Chongqing University has successfully harnessed the capabilities of ProteinMPNN to explore new territories in protein design. This research was detailed in a publication in the esteemed journal “Frontiers of Computer Science.” The team’s findings suggest that proteins engineered with ProteinMPNN not only outperform those developed through conventional techniques but also exhibit better solubility and stability.

A significant aspect of this research lies in the comprehensive bioinformatics analysis performed as part of the project. The analysis revealed that the novel protein sequences produced by ProteinMPNN exhibited enhanced properties compared to the original synthetic binding proteins. Surprisingly, a finding emerged indicating that sequences derived from monomeric structures demonstrated superior solubility and stability. In contrast, when sequences were designed based on complex structures, they yielded higher calculated binding energies, shedding new insights into the design parameters that govern protein behavior.

Through an exhaustive screening process, the research team identified eight scaffolds characterized by markedly improved solubility and stability. This triumvirate of properties is vital for the functionality of synthetic binding proteins. The identified scaffolds included Neocarzinostatin-based binders, diabodies, CI2-based binders, single-chain variable fragments (scFv), repebodies, Fabs, affilins, and evibodies. Each of these scaffolds presents unique attributes that may help in addressing a variety of clinical challenges, including targeted drug delivery and precision medicine.

The integration of deep learning into protein design is a critical step that could lead to more personalized therapies. By leveraging extensive databases and computational power, ProteinMPNN can identify patterns that are often undetectable by traditional methods. This capability marks a paradigm shift in how scientists view protein engineering and therapeutic development.

Furthermore, the potential impact of these findings extends far beyond mere academic interest. The ability to design synthetic binding proteins with attributes tailored for specific applications could accelerate the development of treatments for diseases that currently have limited therapeutic options. This innovative method could potentially lead to breakthroughs in treating various forms of cancer, autoimmune disorders, and infectious diseases, which can often be resistant to conventional therapies.

In a domain where the need for innovative solutions is ever-present, the ProteinMPNN framework stands out as a testament to the power of interdisciplinary collaboration. The convergence of deep learning technology with molecular biology illustrates the transformative possibilities that arise when expertise from varied fields combine to tackle complex biological challenges. The implications of this research are vast, paving the way for further advancements that future studies might uncover.

As this area of research continues to evolve, the scientific community is keenly aware of both the opportunities and the challenges that lie ahead. The need for rigorous validation and the ongoing refinement of predictive models will be vital in ensuring that the promises of this technology are realized in practical applications. Future studies will undoubtedly focus on expanding the dataset used for training these models, which will be critical in enhancing accuracy and applicability.

In closing, the work by Dr. Weiwei Xue and colleagues represents a bold step forward in protein design. The potential to drastically improve the performance of synthetic binding proteins through an advanced framework like ProteinMPNN signifies a remarkable juncture in biochemical research. Not only does this broaden the horizons for therapeutic applications, but it also holds the promise of ushering in a new era of precision medicine tailored to the unique genetic profiles of individuals. As the field moves forward, the excitement surrounding these advancements continues to grow, with researchers eagerly anticipating the transformative impacts they may yield in the near future.

Subject of Research: Protein design and engineering
Article Title: Expanding the sequence spaces of synthetic binding protein using deep learning-based framework ProteinMPNN
News Publication Date: 15-May-2025
Web References: https://journal.hep.com.cn/fcs/
References: https://doi.org/10.1007/s11704-024-31060-3
Image Credits: Yanlin LI, Wantong JIAO, Ruihan LIU, Xuejin DENG, Feng ZHU, Weiwei XUE

Keywords

Applied sciences, Engineering, Computer science